**Core Concept:** The Reticuloendothelial system (RES) is a group of tissues and organs that play a crucial role in the immune system, phagocytosis, and clearance of particles from the bloodstream. The most common radiopharmaceutical used for imaging the RES is Indium-111 (111In) labeled antibodies or radiolabeled leukocytes.

**Why the Correct Answer is Right:** Option D, Indium-111 (111In) labeled leukocytes, is the correct answer for imaging the Reticuloendothelial system (RES) because it is a radiopharmaceutical that demonstrates the RES's activity. Indium-111 is a radioisotope that emits beta particles which can penetrate about 5mm into tissue, providing sufficient penetration depth to detect the RES's activity in organs like liver, spleen, and bone marrow.

**Why Each Wrong Option is Incorrect:**

A. Gallium-67 (67Ga) labeled leukocytes: Gallium-67 is another radioisotope used for imaging the RES, but it has a lower penetration depth (about 2mm) and is not specific to the RES, making it less effective as compared to Indium-111 labeled leukocytes.

B. Technetium-99m (99mTc) labeled leukocytes: Technetium-99m is also used for imaging the RES, but it is not as effective as Indium-111 due to its lower penetration depth and lack of specificity for the RES.

C. Technetium-99m (99mTc) labeled antibodies: Technetium-99m labeled antibodies can be used for imaging certain tumors, but they are not specific to the Reticuloendothelial system, making them unsuitable for assessing RES activity.

**Clinical Pearl:** The Reticuloendothelial system plays a vital role in immune surveillance, phagocytosis, and the clearance of particles from the bloodstream. Imaging the RES helps diagnose conditions like lymphomas, leukemia, and granulomatous disease. It is crucial to understand the nuances between different radiopharmaceuticals for accurate diagnosis and treatment planning.